Management of Recurrent Psoas Abscess
For recurrent psoas abscess, percutaneous CT-guided drainage combined with prolonged antibiotic therapy (median 48 days) is the recommended first-line approach, but when drainage is inadequate, not feasible, or in critically ill/immunocompromised patients, surgical intervention (open retroperitoneal or laparoscopic drainage) should be pursued to achieve complete source control and prevent further recurrence.
Diagnostic Workup for Recurrence
When facing a recurrent psoas abscess, immediate investigation must identify the underlying cause:
- CT imaging with IV contrast is the diagnostic gold standard 1
- Look specifically for:
- Occult gastrointestinal pathology (appendicitis, diverticulitis, Crohn's disease)
- Vertebral osteomyelitis (present in 25% of cases) 2
- Foreign bodies or retained surgical material
- Genitourinary sources
- Inadequately drained loculations from prior treatment
Critical pitfall: The case report of true recurrence in identical location revealed an impacted appendiceal calculus with diverticulitis that was missed initially—percutaneous drainage alone was insufficient 3. This underscores that recurrence often signals an unaddressed source requiring surgical exploration.
Treatment Algorithm Based on Clinical Status
For Immunocompetent, Non-Critically Ill Patients
First attempt: CT-guided percutaneous drainage + antibiotics
- Drainage should be attempted if technically feasible 4
- However, recurrence rates with conservative/drainage approaches remain high (37.3% for IR drainage, 58.9% for antibiotics alone) 4
Antibiotic duration:
- Minimum 4 days if source control adequate 5
- Median duration of 48 days based on recent outcomes data 2
- Continue up to 7 days based on clinical response and inflammatory markers (CRP, procalcitonin, WBC) 5
Antibiotic selection (adapting intra-abdominal infection guidelines):
- Standard regimen: Piperacillin/tazobactam 4 g/0.5 g q6h or 16 g/2 g continuous infusion 5
- If ESBL risk or inadequate source control: Ertapenem 1 g q24h 5
- Beta-lactam allergy: Eravacycline 1 mg/kg q12h 5
Target pathogens: Staphylococcus aureus (most common), Streptococcus spp., Enterococcus spp., E. coli, Bacteroides fragilis 2, 1. S. aureus is associated with higher mortality 4.
For Critically Ill or Immunocompromised Patients
Surgical drainage is preferred when percutaneous drainage fails or is not feasible 5, 6
Options include:
- Open retroperitoneal drainage: Standard surgical approach with no recurrence in reported series 1
- Laparoscopic drainage: Minimally invasive with complete drainage capability, no recurrence in 6-patient series with 1-year follow-up 7
- Robot-assisted laparoscopic drainage: Emerging option allowing complete drainage/irrigation with faster recovery 8
Antibiotic therapy: Up to 7 days post-drainage based on clinical conditions and inflammatory indices 5
Broad-spectrum coverage:
- Piperacillin/tazobactam 6 g/0.75 g LD then 4 g/0.5 g q6h or continuous infusion 5
- If septic shock: Meropenem 1 g q6h by extended infusion, Doripenem 500 mg q8h extended infusion, or Imipenem/cilastatin 500 mg q6h extended infusion 5
High-Risk Factors Predicting Poor Outcomes
The following factors mandate more aggressive intervention 4:
- Negative cultures (associated with higher recurrence and mortality)
- Chronic kidney disease ≥ Stage 3
- Immunosuppression (present in 44.4% of primary abscesses) 2
- Cardiovascular comorbidities
When to Escalate Beyond Percutaneous Drainage
Indications for surgical intervention 5, 6, 4:
- Recurrence after initial percutaneous drainage (30% recurrence rate with open surgery vs 37.3% with IR drainage) 4
- Technically unfeasible percutaneous access
- Multiloculated abscesses not amenable to catheter drainage
- Ongoing signs of infection beyond 7 days despite appropriate antibiotics and drainage 5
- Need to address underlying pathology (e.g., appendicitis, diverticulitis, vertebral osteomyelitis)
- Critically ill or immunocompromised status when drainage inadequate 5
Special Considerations
Tuberculosis and Brucellosis: Consider in endemic areas or appropriate epidemiological context; identified in selected patients via serological/immunological testing 2. These require prolonged antimicrobial therapy specific to the pathogen.
Spinal epidural extension: Occurs rarely but requires combined neurosurgical decompression with transabdominal psoas drainage 9.
Duration of follow-up: Minimum 1-year surveillance recommended given recurrence patterns 7, 1.
Key Clinical Pitfall
The most critical error is treating recurrent psoas abscess with repeated percutaneous drainage without investigating the underlying cause. Recurrence signals either inadequate source control or undiagnosed pathology requiring definitive surgical management 3. The evidence strongly suggests that after first recurrence, surgical exploration should be strongly considered rather than repeated attempts at percutaneous drainage, particularly given the 58.9% recurrence rate with conservative management 4.